Narnatumab (IMC-RON8) is a humanized antibody targeting the macrophage-stimulating receptor (RON) with antitumor activity, used in advanced malignant solid tumors research.
Purity:
99.57%
CAS Number:
[1188275-92-4]
Target:
c-Met/HGFR
* VAT and and shipping costs not included. Errors and price changes excepted